Feature Channels: Blood

Filters close
Newswise: Research reveals high-risk subtype of relapsed pediatric AML
16-Feb-2022 10:00 AM EST
Research reveals high-risk subtype of relapsed pediatric AML
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital have found a previously overlooked mutation in a subtype of pediatric leukemia that has implications for identifying high-risk patients.

Newswise: Music Therapy Improves Ability to Cope with Pain for Patients with Sickle Cell Disease
Released: 16-Feb-2022 11:40 AM EST
Music Therapy Improves Ability to Cope with Pain for Patients with Sickle Cell Disease
University Hospitals Cleveland Medical Center

A new study from University Hospitals Connor Whole Health found patients with Sickle Cell Disease who participated in music therapy learned new self-management skills and improved their ability to cope with pain.

Released: 15-Feb-2022 5:40 PM EST
UCLA Health at CROI: Presenting the case of a woman with HIV-1 in remission following specialized stem cell transplantation for leukemia
University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers presented today the first case of a U.S. woman living with HIV-1 that is in remission after she received a new combination of specialized stem cell transplants for treatment of acute myeloid leukemia (AML). The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.

Released: 15-Feb-2022 5:05 PM EST
Stem cell infusion boosts sepsis survival in mice
eLife

A one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis, shows a study published today in eLife.

Newswise: Smartphone app can vibrate a single drop of blood to determine how well it clots
8-Feb-2022 8:05 PM EST
Smartphone app can vibrate a single drop of blood to determine how well it clots
University of Washington

Researchers at the University of Washington have developed a new blood-clotting test that uses only a single drop of blood and a smartphone vibration motor and camera.

   
Released: 9-Feb-2022 2:00 PM EST
MD Anderson Research Highlights for February 9, 2022
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a classification system to identify clinically actionable gene fusions, an improved method to culture tumor-infiltrating lymphocytes for non-small cell lung cancer and an effective combination therapy for patients with acute myeloid leukemia carrying specific mutations.

Released: 8-Feb-2022 7:00 AM EST
THC in Cannabis May Reduce Platelet Function
American Physiological Society (APS)

Using marijuana may lead to platelet dysfunction, according to a new study in nonhuman primates. Platelets, a component of blood, play a role in maintaining blood vessel (vascular) health and aid wound healing and placental development during pregnancy. The article is published ahead of print in the American Journal of Physiology-Cell Physiology.

Newswise: Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Released: 7-Feb-2022 12:05 PM EST
Metabolism of COVID-19 Antibodies from Convalescent Plasma Suggests Possible Safe Treatment for High Risk Children
Johns Hopkins Medicine

Johns Hopkins Medicine researchers report that a prospective study of 14 infants and children demonstrated that convalescent plasma — a blood product collected from patients recovered from infections with the coronavirus (SARS-CoV-2) that causes COVID-19— was safe in high risk children infected with or exposed to the virus.

Newswise: Study of Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells
Released: 2-Feb-2022 12:50 PM EST
Study of Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells
Perelman School of Medicine at the University of Pennsylvania

Today, an analysis of these two patients published in Nature from the Penn researchers and colleagues from Children’s Hospital of Philadelphia explains the longest persistence of CAR T cell therapy recorded to date against CLL, and shows that the CAR T cells remained detectable at least a decade after infusion, with sustained remission in both patients.

Released: 2-Feb-2022 10:05 AM EST
Blood Test Could Help Predict a Deadly Pregnancy Complication
Michigan State University

A blood test could help doctors predict which pregnant women are likely to develop a life-threatening condition called pre-eclampsia, a study co-authored by a Michigan State University researcher found.

Released: 28-Jan-2022 10:35 AM EST
Study: Nearly 1 in 7 COVID patients in ICU experienced severe bleeding when given full-dose blood thinners
University at Buffalo

Patients with COVID-19 in the intensive care unit (ICU) prescribed full-dose blood thinners are significantly more likely to experience heavy bleeding than patients prescribed a smaller yet equally effective dose, according to a recent University at Buffalo-led study.

Released: 27-Jan-2022 4:10 PM EST
Pulse oximeter measurements of blood oxygen levels are unreliable in assessing severity of Covid-19 pneumonia across different ethnic groups
University of Nottingham

The severity of Covid-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from a device that measures the level of oxygen in the blood of patients.

Newswise: GW Researchers Create Test to Quickly Identify COVID-19 Infection and Disease Severity
Released: 27-Jan-2022 11:15 AM EST
GW Researchers Create Test to Quickly Identify COVID-19 Infection and Disease Severity
George Washington University

George Washington University researchers have developed a blood test that quickly detects if someone has COVID-19 and predicts how severely the immune system will react to the infection, according to a new study coming out today in PLOS One. The findings could one day lead to a powerful tool to help doctors determine the best treatment plan for people with COVID-19.

Released: 26-Jan-2022 8:05 AM EST
Researchers identify immunological markers for SARS-CoV-2 reinfection
American Society for Microbiology (ASM)

Many experts now predict that COVID-19, which so far has killed more than 5.5 million people worldwide, will remain endemic as new, infectious variants of SARS-CoV-2 emerge.

24-Jan-2022 3:00 AM EST
New Study Validates Benefits of Convalescent Plasma for Some COVID-19 Patients
NYU Langone Health

Transfusions of blood plasma donated by people who have already recovered from infection with the pandemic virus may help other patients hospitalized with COVID-19, a new international study shows.

Newswise: Simulation Models Exercise, Age Effects on Plaque Formation in Arteries
19-Jan-2022 1:20 PM EST
Simulation Models Exercise, Age Effects on Plaque Formation in Arteries
American Institute of Physics (AIP)

In Physics of Fluids, engineers from China use fluid dynamics simulations to study the effect of exercise at various ages on plaque formation in the arteries. The authors considered two arterial geometries, one with a bulging outer artery and the other without, and modeled the effect of exercise and age on blood flow. To model exercise, the authors digitized blood flow measurements from individuals in three age groups and used these flowrates as input to their computational model.

   
Released: 24-Jan-2022 3:40 PM EST
The Latest Research News from the Health Disparities Channel
Newswise

The latest research news from the Health Disparities Channel.

Released: 20-Jan-2022 5:50 PM EST
TV watching linked with potentially fatal blood clots
European Society of Cardiology

Take breaks when binge-watching TV to avoid blood clots, say scientists. The warning comes as a study reports that watching TV for four hours a day or more is associated with a 35% higher risk of blood clots compared with less than 2.5 hours. The research is published today in the European Journal of Preventive Cardiology, a journal of the ESC.1

Released: 20-Jan-2022 5:30 PM EST
‘Superpower’ nano bubbles could treat, prevent current and future strains of SARS-CoV-2
Northwestern University

Scientists at Northwestern Medicine and The University of Texas MD Anderson Cancer Center have identified natural nano-bubbles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients and discovered these nano-sized particles can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.



close
2.35265